Anti-CD130, Mouse-Mono(B-R3), Azide free <Anti-gp130>

データシート※最新のデータシートでない場合があります

• 商品コード：852.060.000
• メーカー：TLS
• 包装：200μl
• 本製品は取扱中止になりました

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Thiel S et al. Internalization of the interleukin 6 signal transducer gp130 does not require activation of the Jak/STAT pathway. Biochem. J. 1998 Feb;330 ( Pt 1):47-54
  Thiel S et al
  1998/01/01
  
• 備考：
  Application: binding
• 参照：
  

• No.： 2
• 文献情報：
  Chevalier S et al. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein. J. Biol. Chem. 1996 Jun;271(25):14764-72
  Chevalier S et al
  1996/01/01
  
• 備考：
  Application: blocking inhibition
• 参照：
  

• No.： 3
• 文献情報：
  Memoli B et al. In vivo modulation of soluble &quot;antagonistic&quot; IL-6 receptor synthesis and release in ESRD. J. Am. Soc. Nephrol. 2005 Apr;16(4):1099-107
  Memoli B et al
  2005/01/01
  
• 備考：
  Application: ELISA
• 参照：
  

• No.： 4
• 文献情報：
  Kube D et al. STAT3 is constitutively activated in Hodgkin cell lines. Blood 2001 Aug;98(3):762-70
  Kube D et al
  2001/01/01
  
• 備考：
  Application: FC
• 参照：
  

• No.： 5
• 文献情報：
  Olivier C et al. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response. J. Biol. Chem. 2000 Feb;275(8):5648-56
  Olivier C et al
  2000/01/01
  
• 備考：
  Application: FC
• 参照：
  

• No.： 6
• 文献情報：
  Waetzig GH et al. N-linked glycosylation is essential for the stability but not the signaling function of the interleukin-6 signal transducer glycoprotein 130. J. Biol. Chem. 2010 Jan;285(3):1781-9
  Waetzig GH et al
  2010/01/01
  
• 備考：
  Application: FC
• 参照：
  

• No.： 7
• 文献情報：
  Jover R et al. Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: molecular mechanism and transcription factors involved. FASEB J. 2002 Nov;16(13):1799-801
  Jover R et al
  2002/01/01
  
• 備考：
  Application: IL-6 inhibition
• 参照：
  

• No.： 8
• 文献情報：
  Taupin JL et al. Identification of agonistic and antagonistic antibodies against gp190, the leukemia inhibitory factor receptor, reveals distinct roles for its two cytokine-binding domains. J. Biol. Chem. 2001 Dec;276(51):47975-81
  Taupin JL et al
  2001/01/01
  
• 備考：
  Application: Inhibiition of LIF receptor formation
• 参照：
  

• No.： 9
• 文献情報：
  Auguste P et al. Signaling of type II oncostatin M receptor. J. Biol. Chem. 1997 Jun;272(25):15760-4
  Auguste P et al
  1997/01/01
  
• 備考：
  Application: Inhibition
• 参照：
  

• No.： 10
• 文献情報：
  Blanchard F et al. Mannose 6-Phosphate/Insulin-like growth factor II receptor mediates internalization and degradation of leukemia inhibitory factor but not signal transduction. J. Biol. Chem. 1999 Aug;274(35):24685-93
  Blanchard F et al
  1999/01/01
  
• 備考：
  Application: Inhibition
• 参照：
  

• No.： 11
• 文献情報：
  Gu ZJ et al. Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop. Blood 1996 Nov;88(10):3972-86
  Gu ZJ et al
  1996/01/01
  
• 備考：
  Application: inhibition
• 参照：
  

• No.： 12
• 文献情報：
  Lebeau B et al. Reconstitution of two isoforms of the human interleukin-11 receptor and comparison of their functional properties. FEBS Lett. 1997 Apr;407(2):141-7
  Lebeau B et al
  1997/01/01
  
• 備考：
  Application: inhibition
• 参照：
  

• No.： 13
• 文献情報：
  Gu ZJ et al. Anti-gp130 transducer monoclonal antibodies specifically inhibiting ciliary neurotrophic factor, interleukin-6, interleukin-11, leukemia inhibitory factor or oncostatin M. J. Immunol. Methods 1996 Mar;190(1):21-7
  Gu ZJ et al
  1996/01/01
  
• 備考：
  Application: Inhibition
• 参照：
  

• No.： 14
• 文献情報：
  M端ller-Newen G et al. Studies on the interleukin-6-type cytokine signal transducer gp130 reveal a novel mechanism of receptor activation by monoclonal antibodies. J. Biol. Chem. 2000 Feb;275(7):4579-86
  M端ller-Newen G et al
  2000/01/01
  
• 備考：
  Application: Inhibition of proliferation
• 参照：
  

• No.： 15
• 文献情報：
  Aoki Y et al. Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus. Blood 2001 Nov;98(10):3042-9
  Aoki Y et al
  2001/01/01
  
• 備考：
  Application: Neutralizing
• 参照：
  

• No.： 16
• 文献情報：
  Burger R et al. Gp130 and ras mediated signaling in human plasma cell line INA-6: a cytokine-regulated tumor model for plasmacytoma. Hematol. J. 2001;2(1):42-53
  Burger R et al
  2001/01/01
  
• 備考：
  Application: neutralizing
• 参照：
  

• No.： 17
• 文献情報：
  Duplomb L et al. Soluble mannose 6-phosphate/insulin-like growth factor II (IGF-II) receptor inhibits interleukin-6-type cytokine-dependent proliferation by neutralization of IGF-II. Endocrinology 2003 Dec;144(12):5381-9
  Duplomb L et al
  2003/01/01
  
• 備考：
  Application: primary in FC
• 参照：
  

• No.： 18
• 文献情報：
  Chautard E et al. Akt signaling pathway: a target for radiosensitizing human malignant glioma. Neuro-oncology 2010 May;12(5):434-43
  Chautard E et al
  2010/01/01
  
• 備考：
  
• 参照：
  

• No.： 19
• 文献情報：
  Gu ZJ et al. Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors. Leukemia 2000 Jan;14(1):188-97
  Gu ZJ et al
  2000/01/01
  
• 備考：
  
• 参照：